Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?

We present a case report of a heart failure patient after heart transplantation due to end-stage ischemic cardiomyopathy with significant clinical and echocardiographic improvement 3 months after the introduction of sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor. This new class o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulin, Dario, Planinic, Zrinka, Habek, Jasna Cerkez, Sikic, Jozica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984019/
https://www.ncbi.nlm.nih.gov/pubmed/32029965
http://dx.doi.org/10.4103/ijp.IJP_562_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984019/
https://www.ncbi.nlm.nih.gov/pubmed/32029965
http://dx.doi.org/10.4103/ijp.IJP_562_18

Ejemplares similares